Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Dominguez-Rodriguez

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Annals of Translational Medicine|November 22, 2016
Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?Alberto Dominguez-Rodriguez
Expert Opinion on Investigational Drugs|August 25, 2012
Melatonin in cardiovascular diseaseAlberto Dominguez-Rodriguez
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 30, 2010
Current role of ischemia-modified albumin in routine clinical practiceAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Expert Review of Cardiovascular Therapy|April 2, 2011
Current role of myeloperoxidase in routine clinical practiceAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Journal of the American College of Cardiology|April 23, 2016
Is it Time for a New Paradigm in Asymptomatic Severe Aortic Stenosis?Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Clinical Cardiology|May 20, 2009
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarctionAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
International Journal of Cardiology|May 29, 2012
Preanalytic conditions of the C-reactive protein are of paramount importance to use as a predictor of cardiovascular disease in clinical practiceAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Lancet (London, England)|April 30, 2013
Hypertrophic cardiomyopathyAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Cardiovascular Research|September 2, 2017
Future strategies for acute cardioprotection: 'melatonin as promising therapy'Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Revista Espanola De Cardiologia (English Ed.)|May 6, 2014
Appropriate use criteria for cardiopulmonary exercise testing in patients with cardiac resynchronization devicesAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Annals of Translational Medicine|November 22, 2016
Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?Alberto Dominguez-Rodriguez
Expert Opinion on Investigational Drugs|August 25, 2012
Melatonin in cardiovascular diseaseAlberto Dominguez-Rodriguez
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 30, 2010
Current role of ischemia-modified albumin in routine clinical practiceAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Expert Review of Cardiovascular Therapy|April 2, 2011
Current role of myeloperoxidase in routine clinical practiceAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Journal of the American College of Cardiology|April 23, 2016
Is it Time for a New Paradigm in Asymptomatic Severe Aortic Stenosis?Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Clinical Cardiology|May 20, 2009
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarctionAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
International Journal of Cardiology|May 29, 2012
Preanalytic conditions of the C-reactive protein are of paramount importance to use as a predictor of cardiovascular disease in clinical practiceAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Lancet (London, England)|April 30, 2013
Hypertrophic cardiomyopathyAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Cardiovascular Research|September 2, 2017
Future strategies for acute cardioprotection: 'melatonin as promising therapy'Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Revista Espanola De Cardiologia (English Ed.)|May 6, 2014
Appropriate use criteria for cardiopulmonary exercise testing in patients with cardiac resynchronization devicesAlberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez
Pageof 17